ArticleeNeuro2026
AAV-Based Bright and Sparse Labeling of Versatile Neurons Adaptable in Cre-Dependent Genetic Backgrounds.
Article in eNeuro, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sparse labeling techniques are essential for morphological analysis of the central nervous system. Various sophisticated strategies have been developed, but conventional methods, such as Golgi-Cox staining and biocytin injection, remain widely used. Recent advances in adeno-associated virus (AAV) technology have enabled sparse neuronal labeling in rodents, either through postnatal AAV injection or by coinjecting a dilute Cre recombinase-expressing driver with a Cre-dependent amplifier. However, postnatal AAV injection requires prior preparation, and Cre-dependent systems are incompatible with Cre-expressing or floxed genetic backgrounds. Here, we present a Cre-orthogonal AAV-based sparse labeling method that utilizes Supernova technology in male and female mice. We employed Flpe recombinase to achieve Cre-independent labeling. A retro-orbital injection of PHP.eB AAVs failed to label neurons, whereas local injection enabled the bright and sparse labeling of multiple neuronal types, including cerebellar neurons. The labeled neurons were sufficiently bright to visualize fine structures, such as dendritic spines, without the need for immunostaining. This method is compatible with both Cre-expressing and floxed genetic backgrounds. Furthermore, we demonstrated that the labeled neurons can be manipulated by the coinjection of a Flpe-dependent third virus. This straightforward and flexible approach is applicable across various genetic backgrounds and can be readily integrated into existing experimental systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.